Location History:
- Rosemére, CA (2001)
- Rosemère, CA (2001)
- Laval, CA (2006)
- Ottawa, CA (2004 - 2010)
Company Filing History:
11 out of 62 
1 out of 1,537 
Years Active: 2001-2010
Title: The Innovative Contributions of William W. Ogilvie
Introduction
William W. Ogilvie is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of medical research, particularly in the development of compounds that inhibit the papilloma virus. With a total of 12 patents to his name, Ogilvie's work has the potential to impact public health positively.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Inhibitors of papilloma virus." This patent describes a compound of formula (I) or its enantiomers or diastereoisomers, which can be used as inhibitors of the papilloma virus E1-E2-DNA complex. The invention also provides a method for treating or preventing human papilloma virus infection, showcasing Ogilvie's commitment to advancing medical science.
Career Highlights
Ogilvie has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim (Canada) Ltd. and Boehringer Ingelheim International GmbH. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to innovative research.
Collaborations
Some of his notable coworkers include Jeffrey O'Meara and Christiane Yoakim. Their collaborative efforts have further enhanced the research and development of effective treatments for viral infections.
Conclusion
William W. Ogilvie's contributions to the field of medical research and his innovative patents demonstrate his dedication to improving health outcomes. His work continues to inspire future advancements in the fight against viral infections.